Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays
Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays
01/15/25, 12:57 PM
Location
san diegoIndustry
biotechnology
health care
analytics
Type
partnership
Sapient, a leader in multi-omics discovery, has partnered with Alamar Biosciences to extend its targeted proteomics services to include high-sensitivity cytokine, chemokine, and neuroinflammatory mediator multiplex and single-plex assays using Alamar’s NULISA™ platform and ARGO® HT system. The partnership further extends Sapient’s comprehensive multi-omics solutions to support the entire drug development pipeline from early discovery through to clinical phases.
Company Info
Location
san diego, california, united states
Additional Info
Sapient is at the forefront of biomarker discovery, utilizing cutting-edge, high-throughput mass spectrometry and biocomputational frameworks to offer unparalleled multi-omics data generation and analysis. By enabling comprehensive biomarker-phenotype mapping across thousands of biosamples, Sapient empowers biopharma sponsors to advance precision drug development beyond genomic insights. Our Human Biology Database — comprising over 100,000 samples — enables rapid drug target identification, biomarker validation, and translational insights across all stages of drug development.
Related People
Unlock Verified Contacts + AI Outreach
Instantly access verified contact emails — and let Fundz AI draft a hyper-personalized message based on their role, company, and your company's offering.
Jh
Jh • Executive
Email hidden • Upgrade to unlock
Trusted by teams at Google, Oracle, HubSpot & more
Unlock Verified Contacts + AI Outreach
Instantly access verified contact emails — and let Fundz AI draft a hyper-personalized message based on their role, company, and your company's offering.
Mh
Mh • Executive
Email hidden • Upgrade to unlock
Trusted by teams at Google, Oracle, HubSpot & more